Frequency and spectrum of PIK3CA somatic mutations in breast cancer
2020-01-01 MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
2019-01-01 Conte, Benedetta; Fabi, Alessandra; Poggio, Francesca; Blondeaux, Eva; Dellepiane, Chiara; D'Alonzo, Alessia; Buono, Giuseppe; Arpino, Grazia; Magri, Valentina; Naso, Giuseppe; Presti, Daniele; Mura, Silvia; Fontana, Andrea; Cognetti, Francesco; Molinelli, Chiara; Pastorino, Simona; Bighin, Claudia; Miglietta, Loredana; Boccardo, Francesco; Lambertini, Matteo; Del Mastro, Lucia
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial
2023-01-01 Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
2018-01-01 Poggio, F; Bruzzone, M; Ceppim, ; Conte, B; Martel, S; Maurer, C; Tagliamento, M; Viglietti, G; DEL MASTRO, L; DE AZAMBUJA, E; Lambertini, M
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
2023-01-01 BRASÓ-MARISTANY, F; Griguolo, G; Chic, N; Pascual, T; Paré, L; Maues, J; Galván, P; Dieci, Mv; Miglietta, F; Giarratano, T; MARTÍNEZ-SÁEZ, O; MARÍN-AGUILERA, M; Schettini, F; Conte, B; Angelats, L; Vidal, M; Adamo, B; Muñoz, M; Sanfeliu, E; González, B; Vivancos, A; Villagrasa, P; Parker, Js; Perou, Cm; Conte, P; Prat, A; Guarneri, V
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
2022-01-01 Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
2020-01-01 Prat, A; Guarneri, V; Paré, L; Griguolo, G; Pascual, T; Dieci, Mv; Chic, N; BRASÓ-MARISTANY, F; Vidal, M; Conte, B; Oliveira, M; Saura, C; Pernas, S; Alarcón, J; LLOMBART-CUSSAC, A; Cortés, J; Manso, L; López, R; Ciruelos, E; Schettini, F; Villagrasa, P; Carey, La; Perou, Cm; Piacentini, F; D'Amico, R; Tagliafico, E; Parker, Js; Conte, P
Update on the management of breast cancer during pregnancy
2020-01-01 Poggio, F.; Tagliamento, M.; Pirrone, C.; Soldato, D.; Conte, B.; Molinelli, C.; Cosso, M.; Fregatti, P.; Del Mastro, L.; Lambertini, M.
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
2021-01-01 Conte, B; Schettini, F; Buono, G; DE PLACIDO, P; Parola, S; Griguolo, G; Fabi, A; Bighin, C; Riccardi, F; Cianniello, D; DE LAURENTIIS, M; Puglisi, F; Pelizzari, G; Bonotto, M; Russo, S; Frassoldati, A; Pazzola, A; Montemurro, F; Lambertini, M; Guarneri, V; Cognetti, F; Locci, M; Generalli, D; Conte, P; DE PLACIDO, S; Giuliano, M; Arpino, G; DEL MASTRO, L
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
2018-01-01 Poggio, Francesca; Bruzzone, Marco; Ceppi, Marcello; Conte, Benedetta; Martel, Samuel; Maurer, Christian; Tagliamento, Marco; Viglietti, Giulia; Del Mastro, Lucia; de Azambuja, Evandro; Lambertini, Matteo
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study
2018-01-01 Lambertini, M; Fontana, V; Massarotti, C; Poggio, F; Dellepiane, C; Iacono, G; Abate, A; Miglietta, L; Ferreccio, C; Pescio, Mc; Conte, B; Blondeaux, E; Bighin, C; D'Alonzo, A; Vaglica, M; Zanardi, E; Boccardo, F; Ballestrero, A; Anserini, P; DEL MASTRO, L
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial
2020-01-01 Conte, B.; Bruzzone, M.; Lambertini, M.; Poggio, F.; Bighin, C.; Blondeaux, E.; De Laurentiis, M.; Valle, E.; Cognetti, F.; Nistico, C.; De Placido, S.; Garrone, O.; Gamucci, T.; Montemurro, F.; Puglisi, F.; Cardinali, B.; Fregatti, P.; Miglietta, L.; Boccardo, F.; Ceppi, M.; Del Mastro, L.
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy
2018-01-01 Poggio, Francesca; Conte, Benedetta; Lambertini, Matteo
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report.
2022-01-01 Schettini, F; Segúí, E; Conte, B; Sanfeliu, E; GONZÁLEZ-FARRE, B; Jares, P; VIDAL-SICART, S; Ganau, S; Cebrecos, I; BRASÓ-MARISTANY, F; Muñoz, M; Prat, A; Vidal, M
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers
2021-01-01 Fregatti, P; Gipponi, M; Giacchino, M; Sparavigna, M; Diaz, R; Fioravanti, E; Cornacchia, C; Conte, B; Lambertini, M; Zoppoli, G; Murelli, F; Toni, Ml; Calabro, Mt; Orsino, L; Friedman, D
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
2019-01-01 Poggio, F; Lambertini, M; Bighin, C; Conte, B; Blondeaux, E; D'Alonzo, A; Dellepiane, C; Buzzatti, G; Molinelli, C; Boccardo, F; DEL MASTRO, L
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
2019-01-01 Dieci, Mv; DEL MASTRO, L; Cinquini, M; Montemurro, F; Biganzoli, L; Cortesi, L; Zambelli, A; Criscitiello, C; Levaggi, A; Conte, B; Calabrese, M; Fiorentino, A; Marchiò, C; Tinterri, C; Fittipaldo, Va; Pappagallo, G; Gori, S
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
2020-01-01 Cattrini, Carlo; Bersanelli, Melissa; Latocca, Maria Maddalena; Conte, Benedetta; Vallome, Giacomo; Boccardo, Francesco
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis
2023-01-01 Schettini, F; MARTÍNEZ-SÁEZ, O; Falato, C; DE SANTO, I; Conte, B; GARCIA-FRUCTUOSO, I; GOMEZ-BRAVO, R; Segúí, E; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Vidal, M; Adamo, B; Muñoz, M; Pascual, T; Ciruelos, E; Perou, Cm; Carey, La; Prat, A
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
2019-01-01 Poggio, Francesca; Lambertini, Matteo; Bighin, Claudia; Conte, Benedetta; Blondeaux, Eva; D'Alonzo, Alessia; Dellepiane, Chiara; Buzzatti, Giulia; Molinelli, Chiara; Boccardo, Francesco; Del Mastro, Lucia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Frequency and spectrum of PIK3CA somatic mutations in breast cancer | 1-gen-2020 | MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A | |
| T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study | 1-gen-2019 | Conte, Benedetta; Fabi, Alessandra; Poggio, Francesca; Blondeaux, Eva; Dellepiane, Chiara; D'Alonzo, Alessia; Buono, Giuseppe; Arpino, Grazia; Magri, Valentina; Naso, Giuseppe; Presti, Daniele; Mura, Silvia; Fontana, Andrea; Cognetti, Francesco; Molinelli, Chiara; Pastorino, Simona; Bighin, Claudia; Miglietta, Loredana; Boccardo, Francesco; Lambertini, Matteo; Del Mastro, Lucia | |
| Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial | 1-gen-2023 | Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L | |
| Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis | 1-gen-2018 | Poggio, F; Bruzzone, M; Ceppim, ; Conte, B; Martel, S; Maurer, C; Tagliamento, M; Viglietti, G; DEL MASTRO, L; DE AZAMBUJA, E; Lambertini, M | |
| HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 | 1-gen-2023 | BRASÓ-MARISTANY, F; Griguolo, G; Chic, N; Pascual, T; Paré, L; Maues, J; Galván, P; Dieci, Mv; Miglietta, F; Giarratano, T; MARTÍNEZ-SÁEZ, O; MARÍN-AGUILERA, M; Schettini, F; Conte, B; Angelats, L; Vidal, M; Adamo, B; Muñoz, M; Sanfeliu, E; González, B; Vivancos, A; Villagrasa, P; Parker, Js; Perou, Cm; Conte, P; Prat, A; Guarneri, V | |
| Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | 1-gen-2022 | Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm | |
| A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation | 1-gen-2020 | Prat, A; Guarneri, V; Paré, L; Griguolo, G; Pascual, T; Dieci, Mv; Chic, N; BRASÓ-MARISTANY, F; Vidal, M; Conte, B; Oliveira, M; Saura, C; Pernas, S; Alarcón, J; LLOMBART-CUSSAC, A; Cortés, J; Manso, L; López, R; Ciruelos, E; Schettini, F; Villagrasa, P; Carey, La; Perou, Cm; Piacentini, F; D'Amico, R; Tagliafico, E; Parker, Js; Conte, P | |
| Update on the management of breast cancer during pregnancy | 1-gen-2020 | Poggio, F.; Tagliamento, M.; Pirrone, C.; Soldato, D.; Conte, B.; Molinelli, C.; Cosso, M.; Fregatti, P.; Del Mastro, L.; Lambertini, M. | |
| T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study | 1-gen-2021 | Conte, B; Schettini, F; Buono, G; DE PLACIDO, P; Parola, S; Griguolo, G; Fabi, A; Bighin, C; Riccardi, F; Cianniello, D; DE LAURENTIIS, M; Puglisi, F; Pelizzari, G; Bonotto, M; Russo, S; Frassoldati, A; Pazzola, A; Montemurro, F; Lambertini, M; Guarneri, V; Cognetti, F; Locci, M; Generalli, D; Conte, P; DE PLACIDO, S; Giuliano, M; Arpino, G; DEL MASTRO, L | |
| Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis | 1-gen-2018 | Poggio, Francesca; Bruzzone, Marco; Ceppi, Marcello; Conte, Benedetta; Martel, Samuel; Maurer, Christian; Tagliamento, Marco; Viglietti, Giulia; Del Mastro, Lucia; de Azambuja, Evandro; Lambertini, Matteo | |
| Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study | 1-gen-2018 | Lambertini, M; Fontana, V; Massarotti, C; Poggio, F; Dellepiane, C; Iacono, G; Abate, A; Miglietta, L; Ferreccio, C; Pescio, Mc; Conte, B; Blondeaux, E; Bighin, C; D'Alonzo, A; Vaglica, M; Zanardi, E; Boccardo, F; Ballestrero, A; Anserini, P; DEL MASTRO, L | |
| Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial | 1-gen-2020 | Conte, B.; Bruzzone, M.; Lambertini, M.; Poggio, F.; Bighin, C.; Blondeaux, E.; De Laurentiis, M.; Valle, E.; Cognetti, F.; Nistico, C.; De Placido, S.; Garrone, O.; Gamucci, T.; Montemurro, F.; Puglisi, F.; Cardinali, B.; Fregatti, P.; Miglietta, L.; Boccardo, F.; Ceppi, M.; Del Mastro, L. | |
| Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy | 1-gen-2018 | Poggio, Francesca; Conte, Benedetta; Lambertini, Matteo | |
| Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report. | 1-gen-2022 | Schettini, F; Segúí, E; Conte, B; Sanfeliu, E; GONZÁLEZ-FARRE, B; Jares, P; VIDAL-SICART, S; Ganau, S; Cebrecos, I; BRASÓ-MARISTANY, F; Muñoz, M; Prat, A; Vidal, M | |
| Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers | 1-gen-2021 | Fregatti, P; Gipponi, M; Giacchino, M; Sparavigna, M; Diaz, R; Fioravanti, E; Cornacchia, C; Conte, B; Lambertini, M; Zoppoli, G; Murelli, F; Toni, Ml; Calabro, Mt; Orsino, L; Friedman, D | |
| Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review | 1-gen-2019 | Poggio, F; Lambertini, M; Bighin, C; Conte, B; Blondeaux, E; D'Alonzo, A; Dellepiane, C; Buzzatti, G; Molinelli, C; Boccardo, F; DEL MASTRO, L | |
| Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) | 1-gen-2019 | Dieci, Mv; DEL MASTRO, L; Cinquini, M; Montemurro, F; Biganzoli, L; Cortesi, L; Zambelli, A; Criscitiello, C; Levaggi, A; Conte, B; Calabrese, M; Fiorentino, A; Marchiò, C; Tinterri, C; Fittipaldo, Va; Pappagallo, G; Gori, S | |
| Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer | 1-gen-2020 | Cattrini, Carlo; Bersanelli, Melissa; Latocca, Maria Maddalena; Conte, Benedetta; Vallome, Giacomo; Boccardo, Francesco | |
| Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis | 1-gen-2023 | Schettini, F; MARTÍNEZ-SÁEZ, O; Falato, C; DE SANTO, I; Conte, B; GARCIA-FRUCTUOSO, I; GOMEZ-BRAVO, R; Segúí, E; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Vidal, M; Adamo, B; Muñoz, M; Pascual, T; Ciruelos, E; Perou, Cm; Carey, La; Prat, A | |
| Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review | 1-gen-2019 | Poggio, Francesca; Lambertini, Matteo; Bighin, Claudia; Conte, Benedetta; Blondeaux, Eva; D'Alonzo, Alessia; Dellepiane, Chiara; Buzzatti, Giulia; Molinelli, Chiara; Boccardo, Francesco; Del Mastro, Lucia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista36138
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa62
- 2020 - 20269879
- 2010 - 201913041
- 2000 - 20097282
- 1990 - 19994152
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B771
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICAL REVIEW LETTERS295
- THE EUROPEAN PHYSICAL JOURNAL. C,...284
- PHYSICAL REVIEW D234
- JOURNAL OF HIGH ENERGY PHYSICS183
- PLOS ONE181
- BLOOD169
- INTERNATIONAL JOURNAL OF MOLECULA...164
- NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
- Humans1437
- Female757
- Male607
- Middle Aged459
- Adult415
- Aged406
- COVID-19344
- Italy298
- Animals217
- Treatment Outcome196
Lingua
- eng24740
- ita5290
- fre259
- spa169
- ger58
- rus29
- und26
- por17
- lat15
- grc6
Accesso al fulltext
- no fulltext21423
- reserved7313
- open4964
- restricted2323
- partially open90
- embargoed17
- mixed9